Benralizumab
Term · Oncology and biomedicine · MLC-T-ONC-011953
An afucosylated, humanized monoclonal antibody against the alpha chain of the interleukin-5 receptor (IL-5Ra), with potential anti-asthmatic activity. Upon administration, benralizumab binds to IL-5Ra and elicits an antibody-directed cell cytotoxicity (ADCC) against IL-5Ra-expressing cells. This induces apoptosis in IL-5Ra-expressing cells and may reduce asthmatic episodes. IL-5Ra, expressed on both eosinophils and basophils, plays a key role in asthma.
| Identifier | MLC-T-ONC-011953 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-CD125 humanized monoclonal antibody, IgG1-kappa |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011953",
"term": "Benralizumab",
"field": "Oncology and biomedicine",
"definition": "An afucosylated, humanized monoclonal antibody against the alpha chain of the interleukin-5 receptor (IL-5Ra), with potential anti-asthmatic activity. Upon administration, benralizumab binds to IL-5Ra and elicits an antibody-directed cell cytotoxicity (ADCC) against IL-5Ra-expressing cells. This induces apoptosis in IL-5Ra-expressing cells and may reduce asthmatic episodes. IL-5Ra, expressed on both eosinophils and basophils, plays a key role in asthma.",
"synonyms": [
"anti-CD125 humanized monoclonal antibody, IgG1-kappa"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/benralizumab/"
}
Record 3,433 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.